| A Structure–Activity Relationship Study of Bitopic N6-Substituted Adenosine Derivatives as Biased Adenosine A1 Receptor Agonists L Aurelio, JA Baltos, L Ford, ATN Nguyen, M Jorg, SM Devine, C Valant, ... Journal of medicinal chemistry 61 (5), 2087-2103, 2018 | 28 | 2018 |
| API ionic liquids: probing the effect of counterion structure on physical form and lipid solubility L Ford, E Tay, TH Nguyen, HD Williams, H Benameur, PJ Scammells, ... RSC advances 10 (22), 12788-12799, 2020 | 17 | 2020 |
| Biocompatible cationic lipoamino acids as counterions for oral administration of API-ionic liquids A Lai, N Leong, D Zheng, L Ford, TH Nguyen, HD Williams, H Benameur, ... Pharmaceutical Research 39 (10), 2405-2419, 2022 | 4 | 2022 |
| Catechols as sources of hydrogen atoms in radical deiodination and related reactions G Povie, L Ford, D Pozzi, V Soulard, G Villa, P Renaud Angewandte Chemie International Edition 55 (37), 11221-11225, 2016 | 30 | 2016 |
| Computational and experimental models of type III lipid-based formulations of loratadine containing complex nonionic surfactants AG Guruge, DB Warren, H Benameur, L Ford, HD Williams, V Jannin, ... Molecular Pharmaceutics 18 (12), 4354-4370, 2021 | 5 | 2021 |
| Cyclosporin structure and permeability: from A to Z and beyond KM Corbett, L Ford, DB Warren, CW Pouton, DK Chalmers Journal of Medicinal Chemistry 64 (18), 13131-13151, 2021 | 54 | 2021 |
| Development of Novel Free-radical Reduction Methodology L Ford University of Melbourne, School of Chemistry, 2007 | | 2007 |
| Discovery and in vivo evaluation of alcohol-containing benzothiazoles as potent dual-targeting bacterial DNA supercoiling inhibitors JT Palmer, LC Axford, S Barker, JM Bennett, M Blair, I Collins, DT Davies, ... Bioorganic & Medicinal Chemistry Letters 24 (17), 4215-4222, 2014 | 21 | 2014 |
| ELIMINATION OF NICKEL FLASH WITH" FERRO LIBERTY COAT" L FORD, K CORBETT, B JD | | 1979 |
| Enhancing the oral absorption of kinase inhibitors using lipophilic salts and lipid-based formulations HD Williams, L Ford, S Han, KJ Tangso, S Lim, DM Shackleford, ... Molecular Pharmaceutics 15 (12), 5678-5696, 2018 | 40 | 2018 |
| Free radical hydrostannylation of unactivated alkenes with chiral trialkylstannanes Y Kavanagh, L Ford, CH Schiesser Organometallics 30 (16), 4387-4392, 2011 | 9 | 2011 |
| Further studies on the biodegradation of ionic liquids L Ford, JR Harjani, F Atefi, MT Garcia, RD Singer, PJ Scammells Green chemistry 12 (10), 1783-1789, 2010 | 65 | 2010 |
| Grignard reactions in pyridinium and phosphonium ionic liquids L Ford, F Atefi, RD Singer, PJ Scammells European Journal of Organic Chemistry 2011 (5), 942-950, 2011 | 33 | 2011 |
| Highly Functionalized and Potent Antiviral Cyclopentane Derivatives Formed by a Tandem Process Consisting of Organometallic, Transition‐Metal‐Catalyzed, and Radical Reaction Steps PR Jagtap, L Ford, E Deister, R Pohl, I Císařová, J Hodek, J Weber, ... Chemistry–A European Journal 20 (33), 10298-10304, 2014 | 20 | 2014 |
| Ionic liquid forms of the antimalarial lumefantrine in combination with LFCS type IIIB lipid-based formulations preferentially increase lipid solubility, in vitro … E Tay, TH Nguyen, L Ford, HD Williams, H Benameur, PJ Scammells, ... Pharmaceutics 12 (1), 17, 2019 | 30 | 2019 |
| Ionic liquid forms of weakly acidic drugs in oral lipid formulations: preparation, characterization, in vitro digestion, and in vivo absorption studies Y Sahbaz, TH Nguyen, L Ford, CL McEvoy, HD Williams, PJ Scammells, ... Molecular Pharmaceutics 14 (11), 3669-3683, 2017 | 59 | 2017 |
| Ionic liquids provide unique opportunities for oral drug delivery: structure optimization and in vivo evidence of utility HD Williams, Y Sahbaz, L Ford, TH Nguyen, PJ Scammells, CJH Porter Chemical Communications 50 (14), 1688-1690, 2014 | 151 | 2014 |
| Lipophilic salts and lipid-based formulations: Enhancing the oral delivery of octreotide P Li, L Ford, S Haque, MP McInerney, HD Williams, PJ Scammells, ... Pharmaceutical Research 38 (6), 1125-1137, 2021 | 10 | 2021 |
| Liquid filled formulations of pde5 inhibitors PJ Scammells, CJH Porter, H Benameur, HD Williams, L Ford US Patent App. 16/758,566, 2020 | | 2020 |
| Molecular Dynamics Simulations and Experimental Results Provide Insight into Clinical Performance Differences between Sandimmune® and Neoral® Lipid-Based Formulations DB Warren, S Haque, MP McInerney, KM Corbett, E Kastrati, L Ford, ... Pharmaceutical Research 38, 1531-1547, 2021 | 3 | 2021 |
